Stereotaxis CEO to Present at the 12th Annual BIOMEDevice San Jose Conference
ST. LOUIS, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced today its Chairman and Chief Executive Officer, David Fischel, will present at …